CMG Pharmaceutical Statistics

Total Valuation

CMG Pharmaceutical has a market cap or net worth of KRW 297.92 billion. The enterprise value is 288.52 billion.

Market Cap	297.92B
Enterprise Value	288.52B

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

CMG Pharmaceutical has 138.89 million shares outstanding. The number of shares has decreased by -0.12% in one year.

Shares Outstanding	138.89M
Shares Change (YoY)	-0.12%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	3.69%
Float	103.00M

Valuation Ratios

The trailing PE ratio is 49.25.

PE Ratio	49.25
Forward PE	n/a
PS Ratio	3.20
PB Ratio	1.50
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.51, with an EV/FCF ratio of -12.90.

EV / Earnings	34.83
EV / Sales	3.10
EV / EBITDA	32.51
EV / EBIT	48.73
EV / FCF	-12.90

Financial Position

The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.18.

Current Ratio	3.03
Quick Ratio	2.31
Debt / Equity	0.18
Debt / EBITDA	11.27
Debt / FCF	-1.61
Interest Coverage	1.14

Financial Efficiency

Return on equity (ROE) is 4.26% and return on invested capital (ROIC) is 0.07%.

Return on Equity (ROE)	4.26%
Return on Assets (ROA)	0.06%
Return on Capital (ROIC)	0.07%
Revenue Per Employee	342.60M
Profits Per Employee	30.45M
Employee Count	272
Asset Turnover	0.37
Inventory Turnover	2.43

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.23% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-0.23%
50-Day Moving Average	2,236.10
200-Day Moving Average	2,215.98
Relative Strength Index (RSI)	45.25
Average Volume (20 Days)	285,544

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CMG Pharmaceutical had revenue of KRW 93.19 billion and earned 8.28 billion in profits. Earnings per share was 43.56.

Revenue	93.19B
Gross Profit	40.89B
Operating Income	238.56M
Pretax Income	9.73B
Net Income	8.28B
EBITDA	3.19B
EBIT	238.56M
Earnings Per Share (EPS)	43.56

Full Income Statement

Balance Sheet

The company has 45.40 billion in cash and 36.00 billion in debt, giving a net cash position of 9.40 billion or 67.70 per share.

Cash & Cash Equivalents	45.40B
Total Debt	36.00B
Net Cash	9.40B
Net Cash Per Share	67.70
Equity (Book Value)	198.70B
Book Value Per Share	1,430.58
Working Capital	62.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.47 billion and capital expenditures -28.85 billion, giving a free cash flow of -22.37 billion.

Operating Cash Flow	6.47B
Capital Expenditures	-28.85B
Free Cash Flow	-22.37B
FCF Per Share	-161.07

Full Cash Flow Statement

Margins

Gross margin is 43.88%, with operating and profit margins of 0.26% and 8.89%.

Gross Margin	43.88%
Operating Margin	0.26%
Pretax Margin	10.44%
Profit Margin	8.89%
EBITDA Margin	3.43%
EBIT Margin	0.26%
FCF Margin	-24.01%

Dividends & Yields

CMG Pharmaceutical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.12%
Shareholder Yield	0.12%
Earnings Yield	2.03%
FCF Yield	-7.51%

Stock Splits

The last stock split was on August 28, 2007. It was a forward split with a ratio of 2.

Last Split Date	Aug 28, 2007
Split Type	Forward
Split Ratio	2

Scores

CMG Pharmaceutical has an Altman Z-Score of 3.97.

Altman Z-Score	3.97
Piotroski F-Score	n/a